Dermapharm Holding SE (LON:0A5J)
37.10
-0.23 (-0.60%)
At close: Feb 12, 2026
Dermapharm Holding SE Revenue
Dermapharm Holding SE had revenue of 297.73M EUR in the quarter ending September 30, 2025, a decrease of -5.35%. This brings the company's revenue in the last twelve months to 1.17B, up 0.02% year-over-year. In the year 2024, Dermapharm Holding SE had annual revenue of 1.20B with 3.89% growth.
Revenue (ttm)
1.17B EUR
Revenue Growth
+0.02%
P/S Ratio
1.69
Revenue / Employee
330.65K EUR
Employees
3,551
Market Cap
1.73B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.20B | 44.72M | 3.89% |
| Dec 31, 2023 | 1.15B | 110.19M | 10.59% |
| Dec 31, 2022 | 1.04B | 80.46M | 8.38% |
| Dec 31, 2021 | 960.09M | 151.78M | 18.78% |
| Dec 31, 2020 | 808.31M | 93.94M | 13.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| B&M European Value Retail | 5.68B |
| Mitchells & Butlers | 2.71B |
| TP ICAP Group | 2.27B |
| Tate & Lyle | 1.99B |
| Ocado Group | 1.29B |
| Premier Foods | 1.15B |
| Coats Group | 1.10B |
| AJ Bell | 316.92M |